Health Care/Hospital
SERVING MORE THAN LOOKS: MAYBELLINE NEW YORK ANNOUNCES NAOMI OSAKA AS THE BRAND'S FIRST BRAVE TOGETHER AMBASSADOR
The four-time Grand Slam tennis champion and mental health advocate teams up with Maybelline New York for World Mental Health Day to amplify the Brave Together program NEW YORK, Oct. 9, 2024 /PRNewswire/ -- In honor of World Mental Health Day on October 10, Maybelline New York is maximizing it...
2024-10-09 21:00
2373
Baird Medical Lists in the U.S. on the Nasdaq Exchange
Company Rings Opening Bell to Celebrate Closure of Business Combination and Begins Journey as a Public Company; Shares trade under "BDMD" Ticker FORT MILL, S.C., Oct. 9, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading micro...
2024-10-09 20:30
1555
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine
Implantable Neuromodulation System Shows Early Promise in Improving Patient Quality of Life by Reducing Monthly Headache Days and Severity of Migraine Attacks MINNEAPOLIS, Oct. 9, 2024 /PRNewswire/ -- ShiraTronics, a clinical-stage medical device company developing neurostimulation therapies fo...
2024-10-09 20:12
1251
International Collaboration Addresses Rising Cancer Rates in South America
National Comprehensive Cancer Network and Latin American Cooperative Oncology Group to publish cancer treatment guidelines tailored forBrazil. PLYMOUTH MEETING, Pa., Oct. 9, 2024 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the Unite...
2024-10-09 20:07
1183
Nona Biosciences Enters Strategic Collaboration with OverT Bio to Advance Next-Generation Cell Therapies for Solid Tumors
CAMBRIDGE, Mass., Oct. 9, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), today announced a strategic collaboration with OverT Bio, aNew York-based biotechnology company. The collaboration will focus on developing ne...
2024-10-09 20:00
1210
New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts
Current mpox outbreak underscores gaps in access to medical countermeasures to help mitigate the severity of future outbreaks CAMBRIDGE, Mass., Oct. 9, 2024 /PRNewswire/ -- Today, the INTREPID Alliance, a consortium of innovative biopharmaceutical companies dedicated to accelerating antiviral tr...
2024-10-09 19:00
1165
Spring Growth Spurt, Witsbb Vitamin D for Babies Popular at Leading Australian Pharmacy Chains
SYDNEY, Oct. 9, 2024 /PRNewswire/ -- Should newborn babies supplement with vitamin D? How should vitamin D be supplemented? As global consumers' health awareness significantly increases, the demand for nutritional supplements is showing trends towards refinement, diversification, and personalizat...
2024-10-09 16:50
1484
Alpha Fusion Accelerates Astatine-based Drug Discovery with Series B Funding
OSAKA, Japan, Oct. 9, 2024 /PRNewswire/ -- Alpha Fusion, Inc. (CEO: Sunao Fujioka, headquartered in Kita-ku, Osaka), has raised a total of ¥1.02 billion through a Series B funding round. The round was led by SBI Investment Co., Ltd. andOSAKA University Venture Capital, with participation from sev...
2024-10-09 15:23
1272
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma.
NANJING, China, Oct. 9, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") announced that Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation to LBL-024, an anti-PD-L1/4-1BB bispecific antibody indepe...
2024-10-09 13:38
1610
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma.
NANJING, China, Oct. 9, 2024 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs") announced that Center for Drug Evaluation (CDE) of National Medical Products Administration (NMPA) has granted Breakthrough Therapy Designation to LBL-024, an anti-PD-L1/4-1BB bispecific antibody indepe...
2024-10-09 13:32
1290
Tencent Partners with Pfizer to Launch Smart Healthcare Innovation Ecosystem - Zhang Yu Highlights "Dual-Engine" Strategy for Healthcare Digitization
HANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Tencent Health and Pfizer China have launched the "Pfizer Smart Healthcare Innovation Ecosystem" at the "Tides of Qiantang" Conference. This collaboration aims to drive innovation in smart healthcare solutions. Zhang Yu, Vice President of Tencent Hea...
2024-10-09 11:23
1469
Joint Venture Company Established for Incubation of Early Drug Discovery Programs; Investment from Takeda, Astellas and Sumitomo Mitsui Banking
TOKYO, Oct. 8, 2024 /PRNewswire/ -- Ciconia Bioventures Inc. (Representative Director, Founder CEO:Toshio Fujimoto, "Ciconia") today announced its establishment as a joint venture company based on a master agreement signed on April 22, 2024 by Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:...
2024-10-09 10:00
1380
AWAK Transforms into Vivance, Unveiling a New Brand Identity
SINGAPORE, Oct. 9, 2024 /PRNewswire/ -- AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding toVivance. The name, derived from 'viva' and 'advance', embodies vitality and progress - hallmarks of the company's commitment to revolutionizing kidney health. AW...
2024-10-09 08:00
1770
Rege Nephro Co., Ltd. Successfully Completes Series B Funding to Accelerate Kidney Disease Therapy Trials
KYOTO, Japan, Oct. 7, 2024 /PRNewswire/ -- Rege Nephro Co., Ltd. (
https://www.regenephro.co.jp/
2024-10-09 07:39
2785
Baird Medical to Participate in Roth's 3rd Annual Healthcare Opportunities Conference
GUANGZHOU, China, Oct. 8, 2024 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China which has recently expanded into the U.S. market following its receipt of US...
2024-10-09 04:30
1452
High tech specs and adapted World Cup pitch sensors awarded share of £1.5m as finalists in Longitude Prize on Dementia
* AI glasses that help people living with dementia navigate their environment and a smartwatch that learns daily routines to assist in everyday tasks are among five groundbreaking technologies announced as finalists in The Longitude Prize on Dementia * The Longitude Prize on Dementia is a £4....
2024-10-09 02:30
1973
Ubie, Inc. adds Google as an investor in its latest funding round
NEW YORK, Oct. 8, 2024 /PRNewswire/ -- Ubie Inc. is pleased to announce that it
has received investment from Google in its latest funding round.
2024-10-08 21:00
8316
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative
* Werfen, a worldwide leader in specialized diagnostics, becomes the first European company to finalize the partnership agreement to join Seegene's technology-sharing initiative * The two companies will co-establish a NewCo in Spain to serve as a strategic hub inEurope, accelerating global ex...
2024-10-08 21:00
1743
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
GAITHERSBURG, Md., Oct. 8, 2024 /PRNewswire/ -- LakeShore Biopharma Co., Ltd (Nasdaq: LSB) ("LakeShore Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for in...
2024-10-08 20:30
3176
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions
* SK bioscience invested USD 3 million in FinaBio, a U.S. company specializing in next-generation conjugate vaccine technology. * With the agreement, SK bioscience expects to improve the immunogenicity and productivity of conjugate vaccines, including those for pneumoniae and typhoid. * The ...
2024-10-08 20:00
1524
Week's Top Stories
Most Reposted
Cornerstone Robotics Raises over US$70 million Funding to Forge Accessibility in Robotic Surgery
[Picked up by 323 media titles]
2025-01-13 09:05
RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility
[Picked up by 295 media titles]
2025-01-14 21:00
URBAN REVIVO Celebrates Lunar New Year with Unique Collaboration with Artist Mercedes Bellido
[Picked up by 294 media titles]
2025-01-13 10:44
ARK Wealth Black and Diamond Client Summit: Enhancing Wealth Allocation Strategies for a New Era
[Picked up by 281 media titles]
2025-01-17 13:37
LANDI Global Unveils Flagship Cx20: Elevating business efficiency and customer experience with a next-generation Windows-powered terminal
[Picked up by 274 media titles]
2025-01-11 22:30
Most Read
RingConn Takes Center Stage at CES 2025 with Innovative Wearables: Gen 2 and Gen 2 Air
2025-01-11 01:00
6520
Boqii Announces ADS Ratio Change
2025-01-11 05:30
5256
Dunxin Financial Holdings Limited Announces Name Change to Eason Technology Limited
2025-01-11 05:59
5139
